Emodin 6-O-β-D-glucoside
CAS No. 34298-85-6
Emodin 6-O-β-D-glucoside( Glucoemodin )
Catalog No. M24292 CAS No. 34298-85-6
Emodin 6-O-β-D-glucoside can protect barrier integrity and inhibit HMGB1-mediated inflammatory responses, which suggests a potential use as a therapy for sepsis or septic shock.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 331 | In Stock |
|
| 10MG | 495 | In Stock |
|
| 25MG | 798 | In Stock |
|
| 50MG | 1098 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEmodin 6-O-β-D-glucoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionEmodin 6-O-β-D-glucoside can protect barrier integrity and inhibit HMGB1-mediated inflammatory responses, which suggests a potential use as a therapy for sepsis or septic shock.
-
DescriptionEmodin 6-O-β-D-glucoside can protect barrier integrity and inhibit HMGB1-mediated inflammatory responses, which suggests a potential use as a therapy for sepsis or septic shock. Emodin 6-O-beta-D-glucoside has anti-inflammatory activities and also may have significant therapeutic benefits against diabetic complications and atherosclerosis.
-
In VitroEmodin-6-O-β-D-glucoside (0~20 μM; 24 hours; HUVECs) does not affect cell viability.Emodin-6-O-β-D-glucoside (0~10 μM; 6 hours; HUVECs) results in a dose dependent decrease in high glucose-mediated membrane disruption, inhibits high glucose-induced increase expression of VCAM-1, ICAM-1 and E-selectin and results in decreased expression levels of high glucose-induced MCP-1 and IL-8 mRNA.Emodin-6-O-β-D-glucoside (10 μM; 6 hours; HUVECs) results in a decrease in the number of THP-1 cells adhering to high glucose-induced HUVECs.Emodin-6-O-β-D-glucoside pretreatment significantly inhibits high-glucose-induced ROS formation and p65 NF-κB expression levels increase. Cell Viability Assay Cell Line:HUVECs Concentration:0~20 μM Incubation Time:24 hours Result:Did not affect cell viability.Western Blot Analysis Cell Line:HUVECs Concentration:0~10 μM Incubation Time:6 hours Result:Inhibited high glucose-induced increase expression of VCAM-1, ICAM-1 and E-selectin.RT-PCRCell Line:HUVECs Concentration:0~10 μM Incubation Time:6 hours Result:Resulted in decreased expression levels of high glucose-induced MCP-1 and IL-8 mRNA.Immunofluorescence Cell Line:HUVECsConcentration:10 μM Incubation Time:6 hours Result:Resulted in a decrease in the number of THP-1 cells adhering to high glucose-induced HUVECs.
-
In VivoEmodin-6-O-β-D-glucoside (0~9 mg/mouse; i.v.) markly inhibits peritoneal leakage of dye induced by high glucose. Animal Model:Mouse Dosage:0~9 mg/mouse Administration:I.v.Result:Markly inhibited peritoneal leakage of dye induced by high glucose.
-
SynonymsGlucoemodin
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number34298-85-6
-
Formula Weight432.38
-
Molecular FormulaC21H20O10
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc(cc1C(c2cc(O[C@@H]([C@@H]([C@H]3O)O)O[C@H](CO)[C@H]3O)cc(O)c22)=O)cc(O)c1C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moon C, et al. Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res. 2009 Mar 9;10(1):18.
molnova catalog
related products
-
Tetroquinone
Tetrahydroxy-1,4-benzoquinone, also called tetrahydroxy-p-benzoquinone, tetrahydroxybenzoquinone, or tetrahydroxyquinone (THBQ, THQ), is an organic compound with formula C6O2(OH)4.
-
Methyl sinapate
Methyl sinapate can increase the frequency of cells with chromosome aberrations in the CHO K-1 cells treated with MMC, 4NQO or UV.
-
TET 830 modified/T -...
TET 830 modified/T - helper epitope from tetanus toxoid
Cart
sales@molnova.com